Dr. Allison Grace Roy, MD

Dr. Roy practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Roy's NPI, 1245678291, was assigned on June 12, 2013. Dr. Roy graduated from University of Vermont College of Medicine in 2013. Dr. Roy holds New York license 307227.

Dr. Roy's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Roy's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Dr. Roy is also affiliated with Crouse Hospital. The medical group on file is University OB/GYN Associates. Dmand AI also links Dr. Roy to 3 more hospitals, 1 group practice or clinic, 1 hospice and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roy practices, 8 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Roy's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Roy's licenses on file in 2 states: New York and Pennsylvania.

CMS data shows 274 Medicare services from Dr. Roy across 7 procedure codes in 2024, for 129 Medicare patients. Medicare paid $32,460 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 129 Medicare patients who saw Dr. Roy in 2024. The largest group is 65 to 74, with 57 patients. 74% of them have high blood pressure, and 72% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roy's median patient age at 63, with 100% women.

In 2024, Dr. Roy wrote 230 Medicare Part D claims for 80 patients. 87% of them were for generic drugs. CMS names the drug for 111 of them, across 7 drugs with 11 or more claims each, at $1,453 in total drug cost. In 2023, CMS named 212 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Roy for performance year 2024, reported as part of a group. Dr. Roy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roy as offering telehealth. CMS counts 28 procedures of removal of the uterus by Dr. Roy, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Roy, published from 2020 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Hysterectomy, Ovarian Neoplasms and Carcinoma. Dr. Roy has published most often in Gynecol Oncol. Dr. Roy's most frequent co-authors are Emily M. Ko, MD, Lori Amanda Cory, MD and Dimitrios Nasioudis, MD.

CMS Open Payments shows 1 general payment to Dr. Roy from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $46.

Dr. Roy graduated from University of Vermont College of Medicine in 2013.